ClinTec winner of the Queen’s Award

Monday, April 25, 2011 12:48 PM

CRO ClinTec International is a recipient of the Queen’s Award for Enterprise.  ClinTec was granted the award under the category of International Trade in recognition of its growth in overseas revenue and business success for the past three years. ClinTec has operations in 40 countries.

ClinTec president, founder and CEO, Dr. Rabinder Buttar, stated: “…We have always recognized the importance of our international opportunities and have been at the forefront of entering the emerging markets of clinical research.  The Queen’s Award for Enterprise in International Trade is a fantastic recognition of the efforts we’ve made…”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs